 |
市場調査レポート
商品コード
1457949
PCR技術の世界市場：市場規模・シェア分析 (製品別・技術別・用途別・エンドユーザー別)、産業需要の予測 (～2030年)PCR Technologies Market Size and Share Analysis by Product, Technique, Application, End User - Global Industry Demand Forecast to 2030 |
||||||
| PCR技術の世界市場：市場規模・シェア分析 (製品別・技術別・用途別・エンドユーザー別)、産業需要の予測 (～2030年) |
|
出版日: 2024年02月01日
発行: Prescient & Strategic Intelligence
ページ情報: 英文 310 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
世界のPCR技術市場は、8.4%のCAGRで成長し、2023年に137億930万米ドル、2030年には236億7,250万米ドルに達する見通しです。
この成長の背景には、遺伝性疾患や感染症の発生が増加していること、診断技術を向上させるための資金が増加していることがあります。さらに、病気の早期診断に対する意識の高まりと製品の開発が、この業界の拡大をさらに後押しします。
北米が市場をリード
北米は2023年に40%のシェアを獲得して業界をリードしており、この10年間を通じて最大であり続けると思われます。これは、感染症の流行が増加していること、主要企業が改良されたPCR装置や消耗品を導入していること、医療インフラが発展していることなどに拠ります。
セグメント別の洞察
2023年、試薬・消耗品カテゴリーは70%のシェアで業界最大のシェアを占め、この10年間も最大です。これは、PCR検査に試薬だけでなく消耗品も定期的に使用されることに起因しています。
リアルタイムPCRのカテゴリーは2023年に業界をリードし、今後数年間はさらに8%という著しい速度で進歩すると思われます。遺伝子発現解析、診断テスト開発、がんの表現型解析を含む様々な用途で世界的に広く採用されている手法です。
診断カテゴリーが最大のシェアを占めています。これは、PCR検査が特定の遺伝的変化や感染症を診断する非常に精密な手段であるためです。
当レポートでは、世界のPCR技術の市場について分析し、市場の基本構造・最新情勢や主な促進・抑制要因、世界全体および地域別・主要国の市場規模の動向見通し (金額ベース、2017～2030年)、製品別・技術別・用途別・エンドユーザー別の詳細動向、現在の市場競争の状況、主要企業のプロファイルなどを調査しております。
目次
第1章 調査範囲
第2章 調査手法
第3章 エグゼクティブサマリー
第4章 市場指標
第5章 業界の展望
- 市場力学
- 動向
- 促進要因
- 抑制要因/課題
- 促進要因/抑制要因の影響分析
- 新型コロナウイルス感染症 (COVID-19) の影響
- ポーターのファイブフォース分析
第6章 世界市場
- 概要
- 市場収益：製品別 (2017～2030年)
- 市場収益：技術別 (2017～2030年)
- 市場収益：用途別 (2017～2030年)
- 市場収益：エンドユーザー別 (2017～2030年)
- 市場収益：地域別 (2017～2030年)
第7章 北米市場
- 概要
- 市場収益：製品別 (2017～2030年)
- 市場収益：技術別 (2017～2030年)
- 市場収益：用途別 (2017～2030年)
- 市場収益：エンドユーザー別 (2017～2030年)
- 市場収益：国別 (2017～2030年)
第8章 欧州市場
第9章 アジア太平洋市場
第10章 ラテンアメリカ市場
第11章 中東・アフリカ (MEA) 市場
第12章 米国市場
- 概要
- 市場収益：製品別 (2017～2030年)
- 市場収益：技術別 (2017～2030年)
- 市場収益：用途別 (2017～2030年)
- 市場収益：エンドユーザー別 (2017～2030年)
第13章 カナダ市場
第14章 ドイツ市場
第15章 フランス市場
第16章 英国市場
第17章 イタリア市場
第18章 スペイン市場
第19章 日本市場
第20章 中国市場
第21章 インド市場
第22章 オーストラリア市場
第23章 韓国市場
第24章 ブラジル市場
第25章 メキシコ市場
第26章 サウジアラビア市場
第27章 南アフリカ市場
第28章 アラブ首長国連邦 (UAE) 市場
第29章 競合情勢
- 市場参入企業とその提供製品/サービスの一覧
- 主要企業の競合ベンチマーク
- 主要企業の製品ベンチマーク
- 最近の戦略展開状況
第30章 企業プロファイル
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- QIAGEN N.V.
- Takara Bio USA Inc.
- Agilent Technologies Inc.
- Standard BioTools Inc.
- Danaher Corporation
- Abbott Laboratories
- Merck Life Science Private Limited
- Becton, Dickinson and Company
- Eppendorf AG
第31章 付録
The PCR technologies market generated USD 13,709.3 million in 2023, which will increase to USD 23,672.5 million, powering at an 8.4% CAGR, by 2030.
The growth is because of the increasing genetic disorders and infectious disease occurrence and rising funding to improve diagnostic technologies. Furthermore, the rising consciousness about early disease diagnosis and development in products will further assist this industry expansion.
The surging need for digital PCR kits and assays, consumables, and reagents, is a major driver for this industry, particularly since the pandemic. As the pandemic broke out, the need for digital PCR tests from life sciences and biotechnology firms substantially increased.
PCR tests were performed in various kinds of settings, from hospitals and airports to shopping malls and stadia, to detect and quarantine patients with the virus.
Additionally, COVID-19 is an important factor for the acceptance of the PCR technology as it was made a mandatory test for flyers across various nations.
The Indian government, in December 2022, made RT-PCR testing for COVID-19 compulsory for passengers coming from China, Japan, Hong Kong, Thailand, Singapore, and South Korea from January 2023 onward.
Moreover, France, in January 2023, prolonged its mandate for COVID-19 tests for people arriving from China. Further, France has urged the other 26 EU member states to test Chinese travelers for the virus.
The U.S. has also placed compulsory COVID-19 tests for individuals arriving from China. Additionally, the U.S. Centers for Disease Control and Prevention said that the nation's citizens should hold plans to travel to Hong Kong, Macau, and China until further notice.
North America is Leading Market
North America led the industry in 2023, with a 40% share, and it will remain the largest throughout this decade. This can be because of the increasing prevalence of infectious diseases, the introduction of improved PCR instruments and consumables by the key players, and the development of the healthcare infrastructure.
Moreover, the growing partnerships between businesses are also aiding the industry expansion.
For example, Takara Bio USA Inc., in October 2022, collaborated with BioExcel Diagnostics Laboratory to develop a new technique for detecting infectious illnesses that result in syndromes and authenticate its efficiency.
Segmentation Insights
In 2023, the reagents and consumables category was the largest contributor to the industry, with a 70% share, and it will remain the largest during this decade. This can be ascribed to the regular use of consumables as well as reagents for PCR testing.
The real-time PCR category led the industry in 2023, and will further advance at a significant rate, of 8%, in the coming years. It is an extensively employed method globally for different applications, including gene expression analysis, diagnostic test development, and cancer phenotyping.
The diagnostics category accounted for the largest share. This is because PCR tests are a very precise means to diagnose specific genetic changes and infectious ailments.
Competition Analysis
Major players in this industry are entering into mergers and acquisitions to reach more people, increase their revenue, and improve the technology of their products.
Bio-Rad Laboratories Inc., in August 2022, signed a deal to acquire all the outstanding shares of Curiosity Diagnostics Sp. Z. o. o.'s for USD 170 million.
The contract provided Bio-Rad access to Curiosity Diagnostics' under-development sample-to-answer, rapid polymerase chain reaction system for molecular diagnostics.
With the rising funding to improve diagnostic technologies, the PCR technologies industry will grow significantly in the coming years.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by product
- 1.4.2. Market size breakdown, by technique
- 1.4.3. Market size breakdown, by application
- 1.4.4. Market size breakdown, by end user
- 1.4.5. Market size breakdown, by region
- 1.4.6. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Revenue, by Product (2017-2030)
- 6.3. Market Revenue, by Technique (2017-2030)
- 6.4. Market Revenue, by Application (2017-2030)
- 6.5. Market Revenue, by End User (2017-2030)
- 6.6. Market Revenue, by Region (2017-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Revenue, by Product (2017-2030)
- 7.3. Market Revenue, by Technique (2017-2030)
- 7.4. Market Revenue, by Application (2017-2030)
- 7.5. Market Revenue, by End User (2017-2030)
- 7.6. Market Revenue, by Country (2017-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Revenue, by Product (2017-2030)
- 8.3. Market Revenue, by Technique (2017-2030)
- 8.4. Market Revenue, by Application (2017-2030)
- 8.5. Market Revenue, by End User (2017-2030)
- 8.6. Market Revenue, by Country (2017-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Revenue, by Product (2017-2030)
- 9.3. Market Revenue, by Technique (2017-2030)
- 9.4. Market Revenue, by Application (2017-2030)
- 9.5. Market Revenue, by End User (2017-2030)
- 9.6. Market Revenue, by Country (2017-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Revenue, by Product (2017-2030)
- 10.3. Market Revenue, by Technique (2017-2030)
- 10.4. Market Revenue, by Application (2017-2030)
- 10.5. Market Revenue, by End User (2017-2030)
- 10.6. Market Revenue, by Country (2017-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Revenue, by Product (2017-2030)
- 11.3. Market Revenue, by Technique (2017-2030)
- 11.4. Market Revenue, by Application (2017-2030)
- 11.5. Market Revenue, by End User (2017-2030)
- 11.6. Market Revenue, by Country (2017-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Revenue, by Product (2017-2030)
- 12.3. Market Revenue, by Technique (2017-2030)
- 12.4. Market Revenue, by Application (2017-2030)
- 12.5. Market Revenue, by End User (2017-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Revenue, by Product (2017-2030)
- 13.3. Market Revenue, by Technique (2017-2030)
- 13.4. Market Revenue, by Application (2017-2030)
- 13.5. Market Revenue, by End User (2017-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Revenue, by Product (2017-2030)
- 14.3. Market Revenue, by Technique (2017-2030)
- 14.4. Market Revenue, by Application (2017-2030)
- 14.5. Market Revenue, by End User (2017-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Revenue, by Product (2017-2030)
- 15.3. Market Revenue, by Technique (2017-2030)
- 15.4. Market Revenue, by Application (2017-2030)
- 15.5. Market Revenue, by End User (2017-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Revenue, by Product (2017-2030)
- 16.3. Market Revenue, by Technique (2017-2030)
- 16.4. Market Revenue, by Application (2017-2030)
- 16.5. Market Revenue, by End User (2017-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Revenue, by Product (2017-2030)
- 17.3. Market Revenue, by Technique (2017-2030)
- 17.4. Market Revenue, by Application (2017-2030)
- 17.5. Market Revenue, by End User (2017-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Revenue, by Product (2017-2030)
- 18.3. Market Revenue, by Technique (2017-2030)
- 18.4. Market Revenue, by Application (2017-2030)
- 18.5. Market Revenue, by End User (2017-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Revenue, by Product (2017-2030)
- 19.3. Market Revenue, by Technique (2017-2030)
- 19.4. Market Revenue, by Application (2017-2030)
- 19.5. Market Revenue, by End User (2017-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Revenue, by Product (2017-2030)
- 20.3. Market Revenue, by Technique (2017-2030)
- 20.4. Market Revenue, by Application (2017-2030)
- 20.5. Market Revenue, by End User (2017-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Revenue, by Product (2017-2030)
- 21.3. Market Revenue, by Technique (2017-2030)
- 21.4. Market Revenue, by Application (2017-2030)
- 21.5. Market Revenue, by End User (2017-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Revenue, by Product (2017-2030)
- 22.3. Market Revenue, by Technique (2017-2030)
- 22.4. Market Revenue, by Application (2017-2030)
- 22.5. Market Revenue, by End User (2017-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Revenue, by Product (2017-2030)
- 23.3. Market Revenue, by Technique (2017-2030)
- 23.4. Market Revenue, by Application (2017-2030)
- 23.5. Market Revenue, by End User (2017-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Revenue, by Product (2017-2030)
- 24.3. Market Revenue, by Technique (2017-2030)
- 24.4. Market Revenue, by Application (2017-2030)
- 24.5. Market Revenue, by End User (2017-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Revenue, by Product (2017-2030)
- 25.3. Market Revenue, by Technique (2017-2030)
- 25.4. Market Revenue, by Application (2017-2030)
- 25.5. Market Revenue, by End User (2017-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Revenue, by Product (2017-2030)
- 26.3. Market Revenue, by Technique (2017-2030)
- 26.4. Market Revenue, by Application (2017-2030)
- 26.5. Market Revenue, by End User (2017-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Revenue, by Product (2017-2030)
- 27.3. Market Revenue, by Technique (2017-2030)
- 27.4. Market Revenue, by Application (2017-2030)
- 27.5. Market Revenue, by End User (2017-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Revenue, by Product (2017-2030)
- 28.3. Market Revenue, by Technique (2017-2030)
- 28.4. Market Revenue, by Application (2017-2030)
- 28.5. Market Revenue, by End User (2017-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. F. Hoffmann-La Roche AG
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. Thermo Fisher Scientific Inc.
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
- 30.3. Bio-Rad Laboratories Inc.
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. QIAGEN N.V.
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
- 30.5. Takara Bio USA Inc.
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. Agilent Technologies Inc.
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
- 30.7. Standard BioTools Inc.
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. Danaher Corporation
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
- 30.9. Abbott Laboratories
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
- 30.10. Merck Life Science Private Limited
- 30.10.1. Business overview
- 30.10.2. Product and service offerings
- 30.10.3. Key financial summary
- 30.11. Becton, Dickinson and Company
- 30.11.1. Business overview
- 30.11.2. Product and service offerings
- 30.11.3. Key financial summary
- 30.12. Eppendorf AG
- 30.12.1. Business overview
- 30.12.2. Product and service offerings
- 30.12.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
